FLT3 drugs for Acute Myeloid Leukemia

5 tracked FLT3 drugs in the Acute Myeloid Leukemia race. The class explanation lives on the FLT3 page; the full indication pipeline across every mechanism is on the Acute Myeloid Leukemia page.

2 approved / phase 42 Phase 31 Phase 1

Head-to-head evidence: Clifutinib Besylate vs Gilteritinib · Clifutinib Besylate vs Quizartinib · Gilteritinib vs Quizartinib · Gilteritinib vs XY0206 · anti-CI135 CAR-T vs Gilteritinib · Quizartinib vs XY0206

The roster

← all FLT3 drugs